Kyleena 19,5 mg intrauterines Wirkstofffreisetzungssystem
Country: Germany
Language: German
Source: BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Levonorgestrel
Available from:
AxiCorp Pharma GmbH (8055874)
Dosage:
19,5 mg
Pharmaceutical form:
Intrauterines Wirkstofffreisetzungssystem
Composition:
Teil 1 - Intrauterines Wirkstofffreisetzungssystem; Levonorgestrel (03335) 19,5 Milligramm
Administration route:
intrauterine Anwendung
Authorization status:
zugelassen
Authorization date:
2021-10-04
